Unknown to most people is the fact that over 8 million North Americans are suffering from psoriasis, a chronic, painful, unsightly, and often emotionally devastating disease.
Unfortunately, there's no cure, or even one in sight. As a result, psoriasis patients worldwide spend in excess of 7 billion dollars annually on treatments, none of which combine an optimum degree of safety and efficacy.
For the past three years Prime Pharmaceutical Corporation has been researching and developing a new psoriasis treatment which delivers effective results with virtually no side effects or risk to patients - a significant advantage over existing products.
Prime's superior new psoriasis treatment is ready for launch now, and represents a massive market opportunity that will generate exceptional revenues, profits and wealth for its shareholders.